Home/Filings/4/0001164710-04-000029
4//SEC Filing

IGEN INTERNATIONAL INC /DE 4

Accession 0001164710-04-000029

CIK 0000916304operating

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 8:52 AM ET

Size

10.4 KB

Accession

0001164710-04-000029

Insider Transaction Report

Form 4
Period: 2004-02-13
Transactions
  • Disposition to Issuer

    Option to Buy

    2004-02-1310,0000 total
    Exercise: $23.30From: 2001-06-06Exp: 2011-06-06Common Stock (10,000 underlying)
  • Disposition to Issuer

    Option to Buy

    2004-02-134,5000 total
    Exercise: $15.69From: 2000-06-27Exp: 2010-06-27Common Stock (4,500 underlying)
  • Disposition to Issuer

    Common Stock

    2004-02-138,6000 total
Footnotes (3)
  • [F1]Pursuant to Agreement and Plan of Merger ("Agreement and Plan of Merger") dated July 24, 2003 among Roche Holding Ltd, 66 Acquisition Corporation II, IGEN International, Inc. and BioVeris Corporation (formerly known as IGEN Integrated Healthcare, LLC), each share of Common Stock of IGEN International, Inc. has been converted into the right to receive cash in an amount of $47.25, without interest, plus one share of common stock of BioVeris Corporation. The Agreement is more fully described in th e Registration Statement on Form S-4 (333-109196) as filed with the Securities and Exchange Commission on January 13, 2004.
  • [F2]This option, which provided for vesting in installments, was cancelled in the Agreement and Plan of Merger, and in accordance therewith, each share under option was exchanged for a cash payment of $31.56 (representing the difference between the exercise price of the option and $47.25 per share) plus one (1) share of common stock of BioVeris Corporation.
  • [F3]This option, which provided for vesting in installments, was cancelled in the Agreement and Plan of Merger, and in accordance therewith, each share under option was exchanged for a cash payment of $23.95 (representing the difference between the exercise price of the option and $47.25 per share) plus one (1) share of common stock of BioVeris Corporation.

Issuer

IGEN INTERNATIONAL INC /DE

CIK 0000916304

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000916304

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:52 AM ET
Size
10.4 KB